Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study

Clinical trials in psychiatry second edition: By BS Everitt, S Wessely. Chichester: Wiley, 2008. 236 pp, ISBN no: 978-0-470-51302-6.

(2010) Ray W. Jones   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Memantine Therapy for Alzheimer Disease in Real-world Practice

(2009) Jean-Sébastien Vidal et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis

(2009) Martin R. Farlow et al.   CURRENT MEDICAL RESEARCH AND OPINION

Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer’s Disease: Systematic Review of the ‘Real-World’ Evidence

(2009) I.A. Lockhart et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)

(2009) Jason T. Olin et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

(2009) O L Lopez et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research

Pharmacodynamics of Memantine: An Update

(2008) C. Parsons et al.   Current Neuropharmacology

Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain

(2006) Catherine E. Creeley et al.   NEUROBIOLOGY OF AGING